Annual Operating Profit
-$170.28 M
-$42.84 M-33.62%
December 31, 2023
Summary
- As of February 7, 2025, ALXO annual operating income is -$170.28 million, with the most recent change of -$42.84 million (-33.62%) on December 31, 2023.
- During the last 3 years, ALXO annual operating profit has fallen by -$126.61 million (-289.98%).
- ALXO annual operating profit is now -1144.36% below its all-time high of -$13.68 million, reached on December 31, 2018.
Performance
ALXO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$32.57 M
+$8.96 M+21.57%
September 30, 2024
Summary
- As of February 7, 2025, ALXO quarterly operating income is -$32.57 million, with the most recent change of +$8.96 million (+21.57%) on September 30, 2024.
- Over the past year, ALXO quarterly operating profit has increased by +$20.71 million (+38.87%).
- ALXO quarterly operating profit is now -973.40% below its all-time high of -$3.03 million, reached on September 30, 2019.
Performance
ALXO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$159.88 M
+$20.71 M+11.47%
September 30, 2024
Summary
- As of February 7, 2025, ALXO TTM operating income is -$159.88 million, with the most recent change of +$20.71 million (+11.47%) on September 30, 2024.
- Over the past year, ALXO TTM operating profit has dropped by -$5.40 million (-3.50%).
- ALXO TTM operating profit is now -3682.28% below its all-time high of -$4.23 million, reached on March 31, 2019.
Performance
ALXO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ALXO Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.6% | +38.9% | -3.5% |
| 3 y3 years | -290.0% | -31.6% | -69.9% |
| 5 y5 years | -1144.4% | -129.2% | -203.8% |
ALXO Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -103.8% | at low | -31.6% | +38.9% | -91.3% | +11.5% |
| 5 y | 5-year | -787.6% | at low | -521.3% | +38.9% | -733.4% | +11.5% |
| alltime | all time | -1144.4% | at low | -973.4% | +38.9% | -3682.3% | +11.5% |
ALX Oncology Holdings Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$32.57 M(-21.6%) | -$159.88 M(-11.5%) |
| Jun 2024 | - | -$41.52 M(+10.0%) | -$180.59 M(+2.7%) |
| Mar 2024 | - | -$37.76 M(-21.4%) | -$175.84 M(+3.3%) |
| Dec 2023 | -$170.28 M(+33.6%) | -$48.02 M(-9.9%) | -$170.28 M(+10.2%) |
| Sep 2023 | - | -$53.27 M(+44.9%) | -$154.47 M(+12.0%) |
| Jun 2023 | - | -$36.78 M(+14.2%) | -$137.88 M(+2.2%) |
| Mar 2023 | - | -$32.20 M(-0.0%) | -$134.89 M(+5.9%) |
| Dec 2022 | -$127.44 M(+52.5%) | -$32.22 M(-12.2%) | -$127.44 M(+3.0%) |
| Sep 2022 | - | -$36.68 M(+8.6%) | -$123.69 M(+10.8%) |
| Jun 2022 | - | -$33.79 M(+36.5%) | -$111.58 M(+18.6%) |
| Mar 2022 | - | -$24.75 M(-13.1%) | -$94.09 M(+12.6%) |
| Dec 2021 | -$83.56 M | -$28.47 M(+15.9%) | -$83.56 M(+14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$24.58 M(+50.8%) | -$72.91 M(+25.4%) |
| Jun 2021 | - | -$16.30 M(+14.7%) | -$58.14 M(+10.5%) |
| Mar 2021 | - | -$14.21 M(-20.3%) | -$52.63 M(+20.5%) |
| Dec 2020 | -$43.66 M(+127.6%) | -$17.82 M(+81.7%) | -$43.66 M(+30.1%) |
| Sep 2020 | - | -$9.81 M(-9.1%) | -$33.57 M(+25.3%) |
| Jun 2020 | - | -$10.79 M(+105.8%) | -$26.80 M(+32.7%) |
| Mar 2020 | - | -$5.24 M(-32.2%) | -$20.20 M(+5.3%) |
| Dec 2019 | -$19.18 M(+40.2%) | -$7.73 M(+154.9%) | -$19.18 M(+67.5%) |
| Sep 2019 | - | -$3.03 M(-27.6%) | -$11.45 M(+36.1%) |
| Jun 2019 | - | -$4.19 M(-0.9%) | -$8.42 M(+99.1%) |
| Mar 2019 | - | -$4.23 M | -$4.23 M |
| Dec 2018 | -$13.68 M | - | - |
FAQ
- What is ALX Oncology Holdings annual operating income?
- What is the all time high annual operating profit for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual operating profit year-on-year change?
- What is ALX Oncology Holdings quarterly operating income?
- What is the all time high quarterly operating profit for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly operating profit year-on-year change?
- What is ALX Oncology Holdings TTM operating income?
- What is the all time high TTM operating profit for ALX Oncology Holdings?
- What is ALX Oncology Holdings TTM operating profit year-on-year change?
What is ALX Oncology Holdings annual operating income?
The current annual operating profit of ALXO is -$170.28 M
What is the all time high annual operating profit for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual operating income is -$13.68 M
What is ALX Oncology Holdings annual operating profit year-on-year change?
Over the past year, ALXO annual operating income has changed by -$42.84 M (-33.62%)
What is ALX Oncology Holdings quarterly operating income?
The current quarterly operating profit of ALXO is -$32.57 M
What is the all time high quarterly operating profit for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly operating income is -$3.03 M
What is ALX Oncology Holdings quarterly operating profit year-on-year change?
Over the past year, ALXO quarterly operating income has changed by +$20.71 M (+38.87%)
What is ALX Oncology Holdings TTM operating income?
The current TTM operating profit of ALXO is -$159.88 M
What is the all time high TTM operating profit for ALX Oncology Holdings?
ALX Oncology Holdings all-time high TTM operating income is -$4.23 M
What is ALX Oncology Holdings TTM operating profit year-on-year change?
Over the past year, ALXO TTM operating income has changed by -$5.40 M (-3.50%)